Monoclonal antibody formulations targeting vascular endothelial growth factor, supplied by pharmaceutical manufacturers to oncology departments in hospitals and cancer clinics. Procured by healthcare procurement teams for intravenous administration in treating solid tumors across various cancer types in clinical settings.